Medidata Solutions (MDSO) Shares Up 7.5%
Medidata Solutions Inc (NASDAQ:MDSO) shot up 7.5% during mid-day trading on Monday . The company traded as high as $81.22 and last traded at $80.55. 1,423,932 shares were traded during mid-day trading, an increase of 190% from the average session volume of 491,810 shares. The stock had previously closed at $74.93.
A number of brokerages recently issued reports on MDSO. William Blair began coverage on Medidata Solutions in a research report on Monday. They issued an “outperform” rating and a $74.93 price objective on the stock. BidaskClub downgraded Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday, January 7th. Zacks Investment Research downgraded Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Monday, January 28th. Leerink Swann began coverage on Medidata Solutions in a research report on Wednesday, January 2nd. They issued a “market perform” rating and a $70.00 price objective on the stock. Finally, TheStreet downgraded Medidata Solutions from a “b” rating to a “c+” rating in a research report on Thursday, December 20th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $82.91.
The company has a quick ratio of 2.71, a current ratio of 2.71 and a debt-to-equity ratio of 0.14. The stock has a market cap of $4.81 billion, a price-to-earnings ratio of 83.91, a PEG ratio of 5.12 and a beta of 1.35.
In other Medidata Solutions news, EVP Daniel Patrick Shannon sold 19,725 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $75.17, for a total transaction of $1,482,728.25. Following the sale, the executive vice president now owns 70,497 shares in the company, valued at $5,299,259.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Rouven Bergmann sold 12,512 shares of the firm’s stock in a transaction dated Wednesday, February 6th. The shares were sold at an average price of $75.00, for a total value of $938,400.00. The disclosure for this sale can be found here. Insiders have sold 47,237 shares of company stock worth $3,568,628 in the last 90 days. Company insiders own 4.70% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Benjamin F. Edwards & Company Inc. increased its holdings in shares of Medidata Solutions by 127.2% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock worth $64,000 after buying an additional 529 shares during the period. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Medidata Solutions by 26.9% in the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,286 shares of the company’s stock worth $87,000 after buying an additional 273 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in shares of Medidata Solutions in the fourth quarter worth about $90,000. Canton Hathaway LLC purchased a new position in shares of Medidata Solutions in the first quarter worth about $109,000. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Medidata Solutions by 1,068.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 2,558 shares of the company’s stock worth $172,000 after buying an additional 2,339 shares during the period.
WARNING: “Medidata Solutions (MDSO) Shares Up 7.5%” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://theolympiareport.com/2019/04/15/medidata-solutions-mdso-shares-up-7-5.html.
Medidata Solutions Company Profile (NASDAQ:MDSO)
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
Featured Article: How Investors Can Profit from Options Trading
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.